About the Acquired Immunity Session
The immune system's adaptive immune system, sometimes referred to as the acquired immune system, is made up of specialised, systemic cells and processes that either destroy infections or stop their growth. One of the two basic types of immunity that may be seen in vertebrates is the acquired immune system. The adaptive immune system, which kills invasive pathogens, is similar to the innate immune system in that it consists of both humoral immunity components and cell-mediated immunity components. The adaptive immune system is very specialised to each unique pathogen the body has faced, in contrast to the innate immune system, which is pre-programmed to respond to common broad categories of pathogen. After an initial reaction to a particular pathogen, adaptive immunity develops immunological memory, which results in an improved response to subsequent encounters with that pathogen. . A crucial component of the adaptive immune system are antibodies. Adaptive immunity can offer enduring defense, sometimes for the duration of a person's lifetime. In some cases, such as with chickenpox, it does not provide lifetime protection; for instance, a person who recovers from measles is now protected against measles for the rest of their lives. The foundation of vaccination is this process of adaptive immunity.
Topics Covered in Acquired Immunity
Humoral and cell-mediated immunity
Antibody production and antigen recognition
Lymphocyte responses in adaptive immunity
Immunological memory and lasting protection
Pathogen-specific immune responses
Vaccine-induced immunity and booster responses
Featured Speakers — Acquired Immunity 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Acquired Immunity Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IPHC 2027
Why Attend the Acquired Immunity Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Acquired Immunity work, reviewed by the scientific committee.
Network Globally
Meet public health researchers, educators, and policy leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Acquired Immunity research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IPHC 2027 for the Acquired Immunity track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Acquired Immunity Conference 2027 — FAQs
What is the Acquired Immunity track at IPHC 2027?
The Acquired Immunity track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Acquired Immunity. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Acquired Immunity sessions?
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Acquired Immunity are all welcome — whether presenting or attending.
Can I present my research in the Acquired Immunity track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Acquired Immunity sessions?
Yes. IPHC 2027 is a hybrid conference — attend the Acquired Immunity track in person in Singapore or join live online, with on-demand access afterward.
Join the IPHC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
